Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by 1wascallywabbiton Feb 24, 2017 2:09pm
312 Views
Post# 25890494

Is this Shorting Round #2

Is this Shorting Round #2Going back to retest the lows? Down 15% from the recent $2.64 high and down 10+% since the very good news that should have rallied the stock. They obviously think that there will be no news soon to catch them with their Shorts down. And the "sell on news" phenom is also having an effect. The "market" is generally an anticipation action, up to 6 months lead time to when things actually turn positive for a company, so that means we should start to move up soon if there is going to be any real positive news b4 end Q3.
Bullboard Posts